[Perspectives] Kevan Herold: untangling type 1 diabetes in the clinic and the lab
One day you might find Kevan Herold working with a humanised mouse model of type 1 diabetes. The next you might find him counselling parents reeling from their child’s diabetes diagnosis. Herold, Director of the Yale Diabetes Center in New Haven, CT, USA, wouldn’t have it any other way. But he fears that he belongs to a shrinking minority of physicians who not only want to run clinical trials of drugs but also to understand the mechanisms by which the drugs work. “What worries me a lot is in spite of all the attention that’s being given to translational medicine, the number of physicians who are actively engaged in science is decreasing”, he says.